Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3193365 | Annals of Allergy, Asthma & Immunology | 2007 | 11 Pages |
Abstract
Until specific tests or clinical markers are identified that will clearly distinguish between patients who will relapse from those who will remain in long-term clinical remission after discontinuing effective allergen immunotherapy, the decision to continue or stop immunotherapy must be individualized.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Linda MD, John R. MD,